Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11814425
APP PUB NO 20200407430A1
SERIAL NO

16784970

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTPβ), and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • EYE POINT PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Michael Glenn Lebanon, US 12 203
Peters, Kevin Gene Cincinnati, US 31 692
Rotello, Rocco Jamie Lebanon, US 6 167

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 14, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00